BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Public health advocate: It is generally true that medications that undergo the extensive FDA Phase III clinical safety

Expert replies
by BTGmoderatorDC » Thu Nov 19, 2020 5:38 pm

Timer

00:00

Answers

A

B

C

D

E

Stats

Difficulty

Public health advocate: It is generally true that medications that undergo the extensive FDA Phase III clinical safety testing are much safer than less-researched drugs. It is also true that whenever such trials are conducted, fewer people have experienced unexpected harmful side effects, thus reducing public health risks. However, eliminating the requirement that even FDA-tested medications continue to include extensive warnings about individual risk factors would almost certainly harm rather than help public health. Consumers would tend to rely on the FDA’s general certification of safety, and if no longer encouraged to read about individual risks and drug interactions, many patients would suffer serious adverse reactions.

The two bolded statements serve what purpose in the context of the public health advocate’s argument?

A The first is a general pattern that the advocate accepts as true; the second is said to be a natural consequence that must follow if the general pattern applies.

B The first is a causal relationship that the advocate believes will happen again in the case at issue; the second admits a situation in which the relationship
would not hold.

C The first describes a cause and effect relationship that the advocate believes will not hold in the case at issue;
the second suggests a consideration that supports that belief.

D The first is proof that the advocate uses to support a prediction; the second states that prediction.

E The first acknowledges a consideration that weighs against the stance that the advocate supports; the second is that stance.


OA C

Source: GMAT Prep
Join the discussion
Source: — Critical Reasoning |